Prosecution Insights
Prosecution Insights
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §112 only | 3 (43%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BANERJEE, KOYELI | 1 | — | — |
| EMCH, GREGORY S | 1 | 48.7% | +43.7% |
| VAN BUREN, LAUREN K | 1 | 39.3% | +57.9% |
| MERTZ, PREMA MARIA | 1 | 71.6% | +35.6% |
| LUNDE, GRACE HENRY | 1 | 63.0% | +38.9% |
| TRAN, KHOA NHAT | 1 | 42.0% | +58.8% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.0% | +16.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025763 | Methods of Determining Immune Response | EMCH, GREGORY S | 66d overdue |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | TRAN, KHOA NHAT | 37d overdue |
| 18287793 | NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS | BANERJEE, KOYELI | — |
| 17926106 | IMMUNE CELLS WITH ENHANCED FUNCTION | VAN BUREN, LAUREN K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025763 | Methods of Determining Immune Response | EMCH, GREGORY S | 66d overdue |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | TRAN, KHOA NHAT | 37d overdue |
| 17926106 | IMMUNE CELLS WITH ENHANCED FUNCTION | VAN BUREN, LAUREN K | — |
| 17781271 | TARGETING EPHA3 AND USES THEREOF | MERTZ, PREMA MARIA | — |
| 17614460 | ANTI-GAL9 IMMUNE-INHIBITING BINDING MOLECULES | LUNDE, GRACE HENRY | — |
| 16964399 | HPV IMMUNOTHERAPY | KINSEY WHITE, NICOLE ERIN | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| 1678 | 1 |
| 1638 | 1 |
| 1674 | 1 |
| 1641 | 1 |
| 1632 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18287793 | NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS | BANERJEE, KOYELI | 1658 | §101§102§103§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18025763 | Methods of Determining Immune Response | EMCH, GREGORY S | 1678 | §102§112 | Non-Final OA | 66d overdue | Pending | Mar 10, 2023 |
| 17926106 | IMMUNE CELLS WITH ENHANCED FUNCTION | VAN BUREN, LAUREN K | 1638 | §102§103 | Final Rejection | — | Pending | Nov 17, 2022 |
| 17781271 | TARGETING EPHA3 AND USES THEREOF | MERTZ, PREMA MARIA | 1674 | §112 | Non-Final OA | — | Pending | May 31, 2022 |
| 17614460 | ANTI-GAL9 IMMUNE-INHIBITING BINDING MOLECULES | LUNDE, GRACE HENRY | 1641 | §112 | Non-Final OA | — | Pending | Nov 26, 2021 |
| 17440081 | CARDIOMYOCYTE PROLIFERATION | TRAN, KHOA NHAT | 1632 | §103§112 | Final Rejection | 37d overdue | Pending | Sep 16, 2021 |
| 16964399 | HPV IMMUNOTHERAPY | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Non-Final OA | — | Pending | Jul 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial